Author:
Bowman Natalie M.,Congdon Seth,Mvalo Tisungane,Patel Jaymin C.,Escamilla Veronica,Emch Michael,Martinson Francis,Hoffman Irving,Meshnick Steven R.,Juliano Jonathan J.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. World Health Organization. World Malaria Report 2012. WHO Publications: Geneva, (2012).
2. RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. New Engl J Med. 365, 1863–1875 (2011).
3. RTS,S Clinical Trials Partnership. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. New Engl J Med. 367, 2284–2295 (2012).
4. Olutu, A., Fegan, G. & Wambua, J. et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. New Engl J Med. 368, 1111–1120 (2013).
5. Calvo-Calle, J. M. et al. Immunogenecity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. J Immunol. 150, 1403–1412 (1993).